stockrowHumana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) Return on equity
Humana Inc.'s return on equity over the twelve months to 30 September 2026 was 6.65%, down 0.3 percentage points from fiscal 2025 (6.95%). Over the past ten years it has ranged from 5.84% (fiscal 2016) to 26.1% (fiscal 2020); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 6.95% | (0.42) |
| FY2024 | 7.37% | (8.34) |
| FY2023 | 15.7% | (2.12) |
| FY2022 | 17.8% | (1.83) |
| FY2021 | 19.7% | (6.48) |
| FY2020 | 26.1% | 1.75 |
| FY2019 | 24.4% | 7.56 |
| FY2018 | 16.8% | (7.02) |
| FY2017 | 23.9% | 18.01 |
| FY2016 | 5.84% | (6.93) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| UNH UnitedHealth Group Incorporated compare | 15.4% |
| CVS CVS Health Corporation compare | 14.4% |
| CI Cigna Group compare | 14.0% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. | 6.65% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement